Merck Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Merck Aktien-Sparplan Merck Aktien-Sparplan

86,40 EUR +0,80 EUR +0,93 %

07.03.2025

FSE

94,58 USD -0,07 USD -0,07 %

nachbörslich07.03.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.219,15 Mrd. EUR

KGV14,77Div. Rendite3,14%

WKNA0YD8Q

ISINUS58933Y1055

SymbolMRK

Merck Aktien News

Sortieren:Datum Meistgelesen

07.03.25PR NewswireMerck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK

06.03.25ZacksMerck (MRK) Ascends While Market Falls: Some Facts to Note

WerbungMerck-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

06.03.25ZacksMerck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?

04.03.25BenzingaSpotlight on Merck & Co: Analyzing the Surge in Options Activity

03.03.25PR NewswireMRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

03.03.25PR NewswireMRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm

28.02.25ZacksMerck (MRK) Exceeds Market Returns: Some Facts to Consider

28.02.25ZacksMerck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

28.02.25PR NewswireMRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

27.02.25BenzingaDecoding Merck & Co's Options Activity: What's the Big Picture?

25.02.25ZacksWall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

25.02.25PR NewswireClass Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky

24.02.25ZacksThe Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis

22.02.25MotleyFoolIs Merck Stock a Buy?

21.02.25ZacksWhy Merck (MRK) is a Great Dividend Stock Right Now

20.02.25Korea TimesMerck highlights materials solutions for new chip architectures at SEMICON Korea

18.02.25BenzingaLooking Into Merck & Co's Recent Short Interest

18.02.25BenzingaBeyond The Numbers: 13 Analysts Discuss Merck & Co Stock

16.02.25PR NewswireMRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

13.02.25BenzingaDecoding Merck & Co's Options Activity: What's the Big Picture?

13.02.25ZacksMerck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

12.02.25Financial TimesChina leaves Merck in need of a new profit injection

11.02.25BenzingaGermany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics

11.02.25BenzingaRecent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock

11.02.25PR NewswireHealth Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination w...

10.02.25MotleyFoolBetter High-Yield Dividend Stock: Pfizer vs. Merck

05.02.25BenzingaAnalysts Defend Merck Amid Investor Concerns Over Weak Guidance

05.02.25ZacksWhy Merck (MRK) is a Top Dividend Stock for Your Portfolio

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.